Review
Open access
Aug 2026
Prospective studies integrating repeat tissue sampling, comprehensive genomic profiling, biomarker-guided patient stratification, pharmacogenomics, functional drug-sensitivity testing where feasible, and integrated multi-omics approaches are needed to advance molecularly guided and individualized treatment for T-SCLC.
Ming-Feng Wei, Zheng Li, Kai Zhu et al.
· Frontiers in Medicine · 0 citations